Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 7
979
Views
41
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Predictability of plasma concentration–time curves in humans using single-species allometric scaling of chimeric mice with humanized liver

, , , , , , , , , , , & show all
Pages 605-614 | Received 18 Nov 2014, Accepted 09 Jan 2015, Published online: 03 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Shogo Matsumoto, Shotaro Uehara, Hidetaka Kamimura, Hiroshi Ikeda, Satoshi Maeda, Machiko Hattori, Megumi Nishiwaki, Kazuhiko Kato & Hiroshi Yamazaki. (2021) Human total clearance values and volumes of distribution of typical human cytochrome P450 2C9/19 substrates predicted by single-species allometric scaling using pharmacokinetic data sets from common marmosets genotyped for P450 2C19. Xenobiotica 51:4, pages 479-493.
Read now
Maki Miyamoto, Yohei Kosugi, Shinji Iwasaki, Ikumi Chisaki, Sayaka Nakagawa, Nobuyuki Amano & Hideki Hirabayashi. (2021) Characterization of plasma protein binding in two mouse models of humanized liver, PXB mouse and humanized TK-NOG mouse. Xenobiotica 51:1, pages 51-60.
Read now
Keigo Nakayama, Soichiro Ito, Masahiro Suzuki, Hiroaki Takubo, Hiroshi Yamazaki & Yukihiro Nomura. (2019) Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver. Xenobiotica 49:4, pages 404-414.
Read now
Maki Miyamoto, Shinji Iwasaki, Ikumi Chisaki, Sayaka Nakagawa, Nobuyuki Amano & Hideki Hirabayashi. (2017) Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver. Xenobiotica 47:12, pages 1052-1063.
Read now
Hidetaka Kamimura, Satoshi Ito, Hiroyuki Chijiwa, Takeshi Okuzono, Tomohiro Ishiguro, Yosuke Yamamoto, Sho Nishinoaki, Shin-Ichi Ninomiya, Marina Mitsui, Amit S. Kalgutkar, Hiroshi Yamazaki & Hiroshi Suemizu. (2017) Simulation of human plasma concentration–time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite using humanized chimeric mice and semi-physiological pharmacokinetic modeling. Xenobiotica 47:5, pages 382-393.
Read now

Articles from other publishers (29)

Kota Hirasawa, Jun Abe, Hirohisa Nagahori & Sachiko Kitamoto. (2023) Novel approach for verification of a human PBPK modeling strategy using chimeric mice in the health risk assessment of epyrifenacil. Toxicology and Applied Pharmacology 465, pages 116439.
Crossref
Go Sugahara, Yuji Ishida, Jae Jin Lee, Meng Li, Yasuhito Tanaka, Hyungjin Eoh, Yusuke Higuchi & Takeshi Saito. (2023) Long‐term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration . The FASEB Journal 37:2.
Crossref
Daigo Asano, Koichi Nakamura, Yumi Nishiya, Hideyuki Shiozawa, Hideo Takakusa, Takahiro Shibayama, Shin-ichi Inoue, Tsuyoshi Shinozuka, Takakazu Hamada, Chizuko Yahara, Nobuaki Watanabe & Kouichi Yoshinari. (2023) Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na V 1.7 Inhibitor DS-1971a, a Mixed Substrate of Cytochrome P450 and Aldehyde Oxidase, Using Chimeric Mice With Humanized Liver . Drug Metabolism and Disposition 51:1, pages 67-80.
Crossref
Kota Hirasawa, Jun Abe, Hirohisa Nagahori & Sachiko Kitamoto. (2022) Prediction of the human pharmacokinetics of epyrifenacil and its major metabolite, S-3100-CA, by a physiologically based pharmacokinetic modeling using chimeric mice with humanized liver. Toxicology and Applied Pharmacology 439, pages 115912.
Crossref
Kosuke Yoshida, Yuki Doi, Norihiko Iwazaki, Hidenori Yasuhara, Yuka Ikenaga, Hidetoshi Shimizu, Tomohisa Nakada, Tomoko Watanabe, Chise Tateno, Seigo Sanoh & Yaichiro Kotake. (2021) Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers. Clinical and Translational Science 15:1, pages 79-91.
Crossref
Shotaro Uehara, Hiroshi Suemizu & Hiroshi Yamazaki. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary 307 328 .
Kohei MatsunagaJun AbeKeiko OgataSatoki FukunagaSachiko Kitamoto. (2021) Elucidation of the species differences of epyrifenacil-induced hepatotoxicity between mice and humans by mass spectrometry imaging analysis in chimeric mice with humanized liver. The Journal of Toxicological Sciences 46:12, pages 601-609.
Crossref
Bappaditya Chatterjee, Pinaki Sengupta & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations 195 277 .
Chise Tateno & Yuha Kojima. (2020) Characterization and applications of chimeric mice with humanized livers for preclinical drug development. Laboratory Animal Research 36:1.
Crossref
Satoshi Ito, Hidetaka Kamimura, Yousuke Yamamoto, Hiroyuki Chijiwa, Takeshi Okuzono, Hiroshi Suemizu & Hiroshi Yamazaki. (2020) Human plasma concentration-time profiles of troglitazone and troglitazone sulfate simulated by in vivo experiments with chimeric mice with humanized livers and semi-physiological pharmacokinetic modeling. Drug Metabolism and Pharmacokinetics 35:6, pages 505-514.
Crossref
Chihiro Yamasaki, Yuji Ishida, Ami Yanagi, Yasumi Yoshizane, Yuha Kojima, Yuko Ogawa, Yutaka Kageyama, Yumiko Iwasaki, Seiichi Ishida, Kazuaki Chayama & Chise Tateno. (2020) Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensional in vitro tool for developing new drugs. PLOS ONE 15:9, pages e0237809.
Crossref
Keigo Nakayama, Hidetaka Kamimura, Hiroshi Suemizu, Nao Yoneda, Megumi Nishiwaki, Kazuhiko Iwamoto, Mari Mizunaga, Tamotsu Negoro, Soichiro Ito, Hiroshi Yamazaki & Yukihiro Nomura. (2020) Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data. Drug Metabolism and Pharmacokinetics 35:4, pages 389-396.
Crossref
Robert S. Jones, Justin Q. Ly & Jae H. Chang. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters 555 594 .
Zheng Lu, Rüdiger Kaspera, Yoichi Naritomi & Tianli Wang. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 671 681 .
Seigo Sanoh, Yuka Tamura, Chieri Fujino, Go SugaharaYasumi YoshizaneAmi YanagiKeishi KisohYuji Ishida, Chise Tateno, Shigeru Ohta & Yaichiro Kotake. (2019) Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver. Biological and Pharmaceutical Bulletin 42:8, pages 1366-1375.
Crossref
Yoichi NaritomiSeigo Sanoh & Shigeru Ohta. (2019) Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with <i>in Vitro</i>–<i>in Vivo</i> Extrapolation and Allometric Scaling. Biological and Pharmaceutical Bulletin 42:3, pages 327-336.
Crossref
Ryuji Watari, Motoharu KakikiChihiro YamasakiYuji IshidaChise TatenoYukie Kuroda, Seiichi Ishida & Kazutomi Kusano. (2019) Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates <i>via</i> a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice. Biological and Pharmaceutical Bulletin 42:3, pages 348-353.
Crossref
Yongjun Hu & David E. Smith. (2019) In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized PepT1 Mice . Drug Metabolism and Disposition 47:3, pages 173-183.
Crossref
Chieri Fujino, Seigo Sanoh, Yuka Tamura, Yuji Ishida, Chise Tateno, Shigeru Ohta & Yaichiro Kotake. (2019) Changes in Bile Acid Concentrations in Chimeric Mice Transplanted with Different Replacement Indexes of Human Hepatocytes. BPB Reports 2:2, pages 29-34.
Crossref
Kaito Nihira, Ken-ichiro Nan-ya, Masakazu Kakuni, Yoko Ono, Yukitaka Yoshikawa, Toshio Ota, Masanori Hiura & Kouichi Yoshinari. (2019) Chimeric Mice With Humanized Livers Demonstrate Human-Specific Hepatotoxicity Caused by a Therapeutic Antibody Against TRAIL-Receptor 2/Death Receptor 5. Toxicological Sciences 167:1, pages 190-201.
Crossref
Karl-Dimiter Bissig, Weiguo Han, Mercedes Barzi, Nataliia Kovalchuk, Liang Ding, Xiaoyu Fan, Francis P. Pankowicz, Qing-Yu Zhang & Xinxin Ding. (2018) P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity. Drug Metabolism and Disposition 46:11, pages 1734-1744.
Crossref
Yoichi Naritomi, Seigo Sanoh & Shigeru Ohta. (2018) Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery. Drug Metabolism and Pharmacokinetics 33:1, pages 31-39.
Crossref
Ryuji Watari, Motoharu KakikiAyumi Oshikata, Toshiaki Takezawa, Chihiro YamasakiYuji IshidaChise TatenoYukie Kuroda, Seiichi Ishida & Kazutomi Kusano. (2018) A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers. The Journal of Toxicological Sciences 43:8, pages 521-529.
Crossref
Seigo Sanoh & Shigeru Ohta. (2018) Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development創薬におけるヒト肝細胞キメラマウスを用いた薬効,毒性および薬物動態評価の有用性. Folia Pharmacologica Japonica 151:5, pages 213-220.
Crossref
Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno & Ryoji Hayashi. (2018) Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver. Drug Metabolism and Disposition 46:1, pages 11-19.
Crossref
Zheng Lu, Rüdiger Kaspera, Yoichi Naritomi & Tianli Wang. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 1 11 .
Seigo Sanoh, Yuto Yamachika, Yuka Tamura, Yaichiro Kotake, Yasumi YoshizaneYuji Ishida, Chise Tateno & Shigeru Ohta. (2017) Assessment of amiodarone-induced phospholipidosis in chimeric mice with a humanized liver. The Journal of Toxicological Sciences 42:5, pages 589-596.
Crossref
E. C. Y. Chow, J. Z. Y. Wang, H. P. Quach, H. Tang, D. C. Evans, A. P. Li, J. Silva & K. S. Pang. (2016) Functional Integrity of the Chimeric (Humanized) Mouse Liver: Enzyme Zonation, Physiologic Spaces, and Hepatic Enzymes and Transporters. Drug Metabolism and Disposition 44:9, pages 1524-1535.
Crossref
Naoyuki Nakada, Akio Kawamura, Hidetaka Kamimura, Koya Sato, Yasuhiro Kazuki, Masakazu Kakuni, Masato Ohbuchi, Kota Kato, Chise Tateno, Mitsuo Oshimura & Takashi Usui. (2016) Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans . Biopharmaceutics & Drug Disposition 37:1, pages 3-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.